We need stronger safeguards around AI systems and biological design tools. We need to recognize that biodefense is national ...
The National Institute of Allergy and Infectious Diseases’s strategic plan for 2026–2030 also omitted emerging infectious ...
Raj Panjabi, former White House Senior Director for Global Health Security and Biodefense, highlights the critical challenges of evaluating emerging biological threats. According to Fortune, ...
The former White House Senior Director for Global Health Security and Biodefense reacted to a Russian lab worker's death from ...
OCALA, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media ...
CHICAGO, June 19, 2025 /PRNewswire/ -- The global biodefense market size is projected to be valued at USD 16.1 billion in 2023 and reach USD 22.8 billion by 2030, growing at a CAGR of 5.0% according ...
More than three years ago, the U.S. government began its tepid response to the COVID-19 pandemic. Without a doubt, there have been missteps and challenges despite the fact that this was not the first ...
Toward a U.S. Biodefense R&D&P Strategy: Recommendations for Action The first step in establishing a successful national biodefense R&D&P program must be clear statements of the importance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results